An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report.
https://ift.tt/3oA8QWj
from WebMD Health https://ift.tt/2RqnvHv
by
An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report.
Comments
Post a Comment